SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Millennium Pharmaceuticals, Inc. (MLNM)
An SI Board Since February 1997
Posts SubjectMarks Bans Symbol
3044 135 0 MLNM
Emcee:  icanpickem Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2019Wasn't it in the PR that you posted? Perhaps a few more details at JPM thisIan@SI-1/12/2004
2018Levin, in an interview on CNBC, stated that Velcade showed activity in NHL and NIRWIN JAMES FRANKEL-1/12/2004
2017Millennium to Highlight 2004 Financial Outlook and Goals at JPMorgan Healthcare IRWIN JAMES FRANKEL-1/12/2004
2016Hi Erik: Really interesting stuff! Thank you very much for sharing it. CathiCathi Wierzbicki-1/7/2004
2015I have "borrowed" the following from Motley Fool's biotech board. Icebrg-1/7/2004
2014Green takes another shot at MLNM - apparently prior to MLNM's press release Ian@SI-1/6/2004
2013Thanks Miljenko, I haven't crossed MLNM off my watch list completely. But Ian@SI-1/6/2004
2012What about NSCLC, PC, Ovarian, H&N,...??? Those were Irino refractory pts, Miljenko Zuanic-1/6/2004
2011i sold too as the stock was up significantly. of course it has rebounded some sibob zagorin-1/6/2004
2010FWIW, I'm now completely out of MLNM. If Velcade turns out to be MM only, tIan@SI-1/6/2004
2009from briefing.com 8:41 am PT MLNM color 17.68 -1.33: Morgan Stanley says they habob zagorin-1/6/2004
2008Time for me to eat some crow. Feuerstein was right. Millennium Responds to MedIan@SI-1/6/2004
2007Erik, Thanks for the clarification. I have looked at the prime output from Ph Ian@SI-1/6/2004
2006Ian >> Since when were Ph IIs designed to evaluate efficacy?>> ThaIcebrg-1/6/2004
20051. I trust Leerink Swann more than I trust Feuerstein. Yesterday, they upgradeIan@SI-1/6/2004
2004(from yahoo board) Adam Feuerstein Millennium Pharma halts Velcade colon cancExtra Pale-1/6/2004
2003Since when were Ph IIs designed to evaluate efficacy? If there were a material Ian@SI-1/6/2004
2002FWIW, Feuerstein on Realmoney.com is saying that MLNM has halted a phase 2 triJFitnich-1/6/2004
2001Some encouraging words from Leerink Swann... * 09:11 ET MLNM upgraded at LeerinIan@SI-1/5/2004
2000Geez those guys at JP Morgan are good. It looks like they've moved San FranIan@SI-1/5/2004
1999thanks! (eom)scaram(o)uche-1/2/2004
1998<I> Did the Taisho program bite the dust permanently, when 977 (CytoMed --software salesperson-1/1/2004
1997Did the Taisho program bite the dust permanently, when 977 (CytoMed ----> Leuscaram(o)uche-1/1/2004
1996FLT3: The Most Popular Current Target [From Medscape's ASH reporting. To meIcebrg-12/31/2003
1995DECEMBER 31, 2003 REPORTER'S NOTEBOOK By Amy Tsao A Tale of Two Biotechbob zagorin-12/31/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News